{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:23:57Z","timestamp":1788279837527,"version":"build-2803163510"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T00:00:00Z","timestamp":1735948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","award":["IR.SBMU.RETECH.REC.1403.709"],"award-info":[{"award-number":["IR.SBMU.RETECH.REC.1403.709"]}],"id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ibroneuroreports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IBRO Neuroscience Reports"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ibneur.2025.01.002","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T18:32:37Z","timestamp":1736361157000},"page":"222-243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Examining the therapeutic potential and side effects of calcium channel blockers in mortality and morbidity of patients with stroke: A systematic review of pre-clinical and clinical studies"],"prefix":"10.1016","volume":"18","author":[{"given":"Sevak","family":"Hatamian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asad","family":"Abdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh Sadat Seyedi","family":"Asl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Tafazolimoghadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arian","family":"Tavasol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Ali Mousavi","family":"Nejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Madadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohre","family":"Tajabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Dehghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najmeh","family":"Ahmadpoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mobina","family":"Fathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Hajiesmaeili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navid","family":"Nooraei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ibneur.2025.01.002_bib1","doi-asserted-by":"crossref","unstructured":"Ahmed, N., P. N\u00e4sman, and N.G.J.S. Wahlgren, Effect of intravenous nimodipine on blood pressure and outcome after acute stroke. 2000. 31(6): p. 1250-1255.","DOI":"10.1161\/01.STR.31.6.1250"},{"issue":"09","key":"10.1016\/j.ibneur.2025.01.002_bib2","first-page":"435","article-title":"Effects of calcium channel blockers on cardiac events, stroke and end-stage renal disease in patients with angina pectoris","volume":"58","author":"Arioka","year":"2008","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ibneur.2025.01.002_bib3","doi-asserted-by":"crossref","unstructured":"Berger, L. and A.M.J.S. Hakim, Calcium channel blockers correct acidosis in ischemic rat brain without altering cerebral blood flow. 1988. 19(10): p. 1257-1261.","DOI":"10.1161\/01.STR.19.10.1257"},{"key":"10.1016\/j.ibneur.2025.01.002_bib4","doi-asserted-by":"crossref","unstructured":"Brooks, K.J. and R.A.J.N..i. Kauppinen, Calcium-mediated damage following hypoxia in cerebral cortex ex vivo studied by NMR spectroscopy. Evidence for direct involvement of voltage-gated Ca2+\u2009-channels. 1993. 23(5): p. 441-450.","DOI":"10.1016\/0197-0186(93)90128-R"},{"key":"10.1016\/j.ibneur.2025.01.002_bib5","doi-asserted-by":"crossref","unstructured":"Bevan, R.D., J.A. Bevan, and J.G.J.S. Frazee, Diltiazem protects against functional changes in chronic cerebrovasospasm in monkeys. 1988. 19(1): p. 73-79.","DOI":"10.1161\/01.STR.19.1.73"},{"key":"10.1016\/j.ibneur.2025.01.002_bib6","doi-asserted-by":"crossref","unstructured":"Brown, R.C., et al., Protection against hypoxia-induced blood-brain barrier disruption: changes in intracellular calcium. 2004. 286(5): p. C1045-C1052.","DOI":"10.1152\/ajpcell.00360.2003"},{"issue":"6","key":"10.1016\/j.ibneur.2025.01.002_bib7","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1080\/03007995.2017.1307817","article-title":"Long-term outcomes of lercanidipine versus other calcium channel blockers in newly diagnosed hypertension: a nationwide cohort study","volume":"33","author":"Cheng","year":"2017","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.ibneur.2025.01.002_bib8","doi-asserted-by":"crossref","unstructured":"Christie-Pope, B.C. and G.C.J.Mbd Palmer, Modulation of ischemic-induced damage to cerebral adenylate cyclase in gerbils by calcium channel blockers. 1986. 1: p. 249-261.","DOI":"10.1007\/BF00999355"},{"issue":"2","key":"10.1016\/j.ibneur.2025.01.002_bib9","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1161\/STROKEAHA.107.495465","article-title":"Predicting stroke risk in hypertensive patients with coronary artery disease: a report from the INVEST","volume":"39","author":"Coca","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.ibneur.2025.01.002_bib10","doi-asserted-by":"crossref","unstructured":"Dens, J., et al., Long term effects of nisoldipine on the progression of coronary atherosclerosis and the occurrence of clinical events: the NICOLE study. 2003. 89(8): p. 887-892.","DOI":"10.1136\/heart.89.8.887"},{"issue":"11","key":"10.1016\/j.ibneur.2025.01.002_bib11","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1007\/s00415-006-0249-1","article-title":"use of calcium channel blockers after stroke is not associated with poor outcome","volume":"253","author":"Dowlatshahi","year":"2006","journal-title":"J. Neurol."},{"key":"10.1016\/j.ibneur.2025.01.002_bib12","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00415-013-7065-1","article-title":"The relationship among restless legs syndrome (Willis\u2013Ekbom Disease), hypertension, cardiovascular disease, and cerebrovascular disease","volume":"261","author":"Ferini-Strambi","year":"2014","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.ibneur.2025.01.002_bib13","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0736-4679(00)00267-5","article-title":"Stroke precipitated by moderate blood pressure reduction","volume":"19","author":"Fischberg","year":"2000","journal-title":"J. Emerg. Med."},{"issue":"11","key":"10.1016\/j.ibneur.2025.01.002_bib14","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1177\/0271678X17705259","article-title":"Intra-arterial verapamil post-thrombectomy is feasible, safe, and neuroprotective in stroke","volume":"37","author":"Fraser","year":"2017","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.ibneur.2025.01.002_bib15","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fphar.2017.00286","article-title":"Discovery and development of calcium channel blockers","volume":"8","author":"Godfraind","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ibneur.2025.01.002_bib16","doi-asserted-by":"crossref","unstructured":"Gomi, S., et al., Failure of levemopamil to improve histological outcome following temporary occlusion of the middle cerebral artery in cats. 1995. 130(2): p. 128-133.","DOI":"10.1016\/0022-510X(95)00014-S"},{"issue":"10","key":"10.1016\/j.ibneur.2025.01.002_bib17","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1097\/00004872-199610000-00013","article-title":"Shanghai trial of nifedipine in the elderly (STONE)","volume":"14","author":"Gong","year":"1996","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ibneur.2025.01.002_bib18","doi-asserted-by":"crossref","unstructured":"Hakim, A., et al., The effect of nimodipine on the evolution of human cerebral infarction studied by PET. 1989. 9(4): p. 523-534.","DOI":"10.1038\/jcbfm.1989.76"},{"issue":"5","key":"10.1016\/j.ibneur.2025.01.002_bib19","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1192\/bjp.2020.249","article-title":"Incidence of neurodegenerative and cerebrovascular diseases associated with antihypertensive drug classes","volume":"218","author":"Harrison","year":"2021","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.ibneur.2025.01.002_bib20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/ijs.12330","article-title":"Comparative effects of antihypertensive drugs on stroke outcome in C hina","volume":"9","author":"Heeley","year":"2014","journal-title":"Int. J. Stroke"},{"key":"10.1016\/j.ibneur.2025.01.002_bib21","doi-asserted-by":"crossref","unstructured":"Hosaka, T., Y. Yamamoto, and M.J.S. Diksic, Efficacy of retrograde perfusion of the cerebral vein with verapamil after focal ischemia in rat brain. 1991. 22(12): p. 1562-1566.","DOI":"10.1161\/01.STR.22.12.1562"},{"issue":"11","key":"10.1016\/j.ibneur.2025.01.002_bib22","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1038\/s41440-019-0300-0","article-title":"Oral short-acting antihypertensive medications and the occurrence of stroke: a nationwide case-crossover study","volume":"42","author":"Hsu","year":"2019","journal-title":"Hypertens. Res."},{"issue":"6","key":"10.1016\/j.ibneur.2025.01.002_bib23","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.cmet.2008.03.010","article-title":"Hypertension and cerebrovascular dysfunction","volume":"7","author":"Iadecola","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.ibneur.2025.01.002_bib24","doi-asserted-by":"crossref","unstructured":"Infeld, B., et al., Nimodipine and perfusion changes after stroke. 1999. 30(7): p. 1417-1423.","DOI":"10.1161\/01.STR.30.7.1417"},{"key":"10.1016\/j.ibneur.2025.01.002_bib25","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s40119-021-00239-1","article-title":"Effect of amlodipine in stroke and myocardial infarction: a systematic review and meta-analysis","volume":"10","author":"Iyengar","year":"2021","journal-title":"Cardiol. Ther."},{"key":"10.1016\/j.ibneur.2025.01.002_bib26","doi-asserted-by":"crossref","unstructured":"Jamerson, K., et al., Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. 2008. 359(23): p. 2417-2428.","DOI":"10.1056\/NEJMoa0806182"},{"issue":"13","key":"10.1016\/j.ibneur.2025.01.002_bib27","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1212\/WNL.0b013e318230201a","article-title":"Short-acting nifedipine and risk of stroke in elderly hypertensive patients","volume":"77","author":"Jung","year":"2011","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ibneur.2025.01.002_bib28","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/joim.13170","article-title":"Calcium channel blockers, survival and ischaemic stroke in patients with dementia: a Swedish registry study","volume":"289","author":"Kalar","year":"2021","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ibneur.2025.01.002_bib29","doi-asserted-by":"crossref","unstructured":"Kawamura, S., et al., Effects of a Ca 2+\u2009entry blocker (nilvadipine) on acute focal cerebral ischemia in rats. 1991. 83: p. 434-438.","DOI":"10.1007\/BF00231169"},{"key":"10.1016\/j.ibneur.2025.01.002_bib30","doi-asserted-by":"crossref","unstructured":"Kawamura, S., et al., Protective effect of nilvadipine on focal cerebral ischemia in spontaneously hypertensive rats. 1996. 36(3): p. 151-155.","DOI":"10.2176\/nmc.36.151"},{"key":"10.1016\/j.ibneur.2025.01.002_bib31","doi-asserted-by":"crossref","unstructured":"Kawamura, S., et al., Effects of treatment with nilvadipine on cerebral ischemia in rats. 1998. 185(4): p. 239-246.","DOI":"10.1620\/tjem.185.239"},{"issue":"1","key":"10.1016\/j.ibneur.2025.01.002_bib32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1161\/STROKEAHA.108.522193","article-title":"Impact of a better adherence to antihypertensive agents on cerebrovascular disease for primary prevention","volume":"40","author":"Kettani","year":"2009","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.ibneur.2025.01.002_bib33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archinte.161.1.37","article-title":"Antihypertensive drug therapies and the risk of ischemic stroke","volume":"161","author":"Klungel","year":"2001","journal-title":"Arch. Intern. Med."},{"issue":"2","key":"10.1016\/j.ibneur.2025.01.002_bib34","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1161\/STROKEAHA.110.600023","article-title":"Recurrent stroke due to a novel voltage sensor mutation in Cav2. 1 responds to verapamil","volume":"42","author":"Knierim","year":"2011","journal-title":"Stroke"},{"issue":"18","key":"10.1016\/j.ibneur.2025.01.002_bib35","doi-asserted-by":"crossref","DOI":"10.1172\/JCI149029","article-title":"Differential restoration of functional hyperemia by antihypertensive drug classes in hypertension-related cerebral small vessel disease","volume":"131","author":"Koide","year":"2021","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ibneur.2025.01.002_bib36","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00424-014-1454-x","article-title":"T-type calcium channel blockers as neuroprotective agents","volume":"466","author":"Kopecky","year":"2014","journal-title":"Pfl\u00fcgers Arch. -Eur. J. Physiol."},{"key":"10.1016\/j.ibneur.2025.01.002_bib37","doi-asserted-by":"crossref","unstructured":"Li, Y., et al., Therapeutic effects of nilvadipine on rat focal cerebral ischemia. 1994. 99: p. 1-6.","DOI":"10.1007\/BF00241406"},{"key":"10.1016\/j.ibneur.2025.01.002_bib38","doi-asserted-by":"crossref","unstructured":"Lin, B., et al., (S)-emopamil protects against global ischemic brain injury in rats. 1990. 21(12): p. 1734-1739.","DOI":"10.1161\/01.STR.21.12.1734"},{"issue":"6","key":"10.1016\/j.ibneur.2025.01.002_bib39","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/0002-8703(86)90376-5","article-title":"Potential efficacy of calcium antagonists and heparin in patients with embolic stroke","volume":"112","author":"Low","year":"1986","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ibneur.2025.01.002_bib40","doi-asserted-by":"crossref","unstructured":"Maniskas, M.E., et al., Stroke neuroprotection revisited: Intra-arterial verapamil is profoundly neuroprotective in experimental acute ischemic stroke. 2016. 36(4): p. 721-730.","DOI":"10.1177\/0271678X15608395"},{"key":"10.1016\/j.ibneur.2025.01.002_bib41","doi-asserted-by":"crossref","unstructured":"Maniskas, M.E., et al., Intra-arterial combination therapy for experimental acute ischemic stroke. 2022. 15(1): p. 279-286.","DOI":"10.1111\/cts.13147"},{"key":"10.1016\/j.ibneur.2025.01.002_bib42","doi-asserted-by":"crossref","unstructured":"Miyazaki, H., et al., Neuroprotective effects of a dihydropyridine derivative, 1, 4-dihydro-2, 6-dimethyl-4-(3-nitrophenyl)-3, 5-pyridinedicarboxylic acid methyl 6-(5-phenyl-3-pyrazolyloxy) hexyl ester (CV-159), on rat ischemic brain injury. 1999. 64(10): p. 869-878.","DOI":"10.1016\/S0024-3205(99)00011-9"},{"key":"10.1016\/j.ibneur.2025.01.002_bib43","doi-asserted-by":"crossref","unstructured":"Najarian, T., T.W.J.N. Traut, and N. Repair, Nifedipine and nimodipine competitively inhibit uridine kinase and orotidine-phosphate decarboxylase: theoretical relevance to poor outcome in stroke. 2000. 14(3): p. 237-241.","DOI":"10.1177\/154596830001400310"},{"key":"10.1016\/j.ibneur.2025.01.002_bib44","doi-asserted-by":"crossref","unstructured":"Napoli, C., et al., 1, 4-Dihydropyridine calcium channel blockers inhibit plasma and LDL oxidation and formation of oxidation-specific epitopes in the arterial wall and prolong survival in stroke-prone spontaneously hypertensive rats. 1999. 30(9): p. 1907-1915.","DOI":"10.1161\/01.STR.30.9.1907"},{"issue":"6","key":"10.1016\/j.ibneur.2025.01.002_bib45","doi-asserted-by":"crossref","first-page":"490","DOI":"10.5551\/jat.42101","article-title":"Effects of cilnidipine, an L\/N-type calcium channel blocker, on carotid atherosclerosis in Japanese post-stroke hypertensive patients: results from the CA-ATTEND study","volume":"25","author":"Nezu","year":"2018","journal-title":"J. Atheroscler. Thromb."},{"issue":"6","key":"10.1016\/j.ibneur.2025.01.002_bib46","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/bph.12240","article-title":"Calcium channel blockers and dementia","volume":"169","author":"Nimmrich","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ibneur.2025.01.002_bib47","first-page":"38","article-title":"Calcium antagonists: current and future applications based on new evidence. Effects of calcium channel blockers on oxidative stress","volume":"20","author":"Nishiyama","year":"2010","journal-title":"Clin. Calcium"},{"key":"10.1016\/j.ibneur.2025.01.002_bib48","doi-asserted-by":"crossref","unstructured":"Nissen, S.E., et al., Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. 2004. 292(18): p. 2217-2225.","DOI":"10.1001\/jama.292.18.2217"},{"key":"10.1016\/j.ibneur.2025.01.002_bib49","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11910-003-0031-z","article-title":"Neuroprotective agents for the treatment of acute ischemic stroke","volume":"3","author":"Ovbiagele","year":"2003","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"1","key":"10.1016\/j.ibneur.2025.01.002_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2261-12-15","article-title":"Correlations between prescription of anti-hypertensive medication and mortality due to stroke","volume":"12","author":"Papp","year":"2012","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.ibneur.2025.01.002_bib51","doi-asserted-by":"crossref","unstructured":"Pepine, C.J., et al., A calcium antagonist vs a non\u2013calcium antagonist hypertension treatment strategy for patients with coronary artery disease: the International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. 2003. 290(21): p. 2805-2816.","DOI":"10.1001\/jama.290.21.2805"},{"key":"10.1016\/j.ibneur.2025.01.002_bib52","doi-asserted-by":"crossref","unstructured":"Phillis, J.W., R. DeLong, and J.J.S. Towner, The effects of nifedipine and felodipine on cerebral blood flow during anoxic episodes. 1986. 17(2): p. 229-234.","DOI":"10.1161\/01.STR.17.2.229"},{"issue":"2","key":"10.1016\/j.ibneur.2025.01.002_bib53","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/0271678X17726624","article-title":"Calcium channel blockade with nimodipine reverses MRI evidence of cerebral oedema following acute hypoxia","volume":"39","author":"Rowland","year":"2019","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.ibneur.2025.01.002_bib54","doi-asserted-by":"crossref","unstructured":"Roy, M.W., et al., Effects of verapamil and diltiazem on acute stroke in cats. 1985. 63(6): p. 929-936.","DOI":"10.3171\/jns.1985.63.6.0929"},{"key":"10.1016\/j.ibneur.2025.01.002_bib55","doi-asserted-by":"crossref","unstructured":"Sakaki, T., et al., The effect of a new calcium antagonist, TA3090 (clentiazem), on experimental transient focal cerebral ischemia in cats. 1993. 24(6): p. 872-878.","DOI":"10.1161\/01.STR.24.6.872"},{"issue":"5-6","key":"10.1016\/j.ibneur.2025.01.002_bib56","first-page":"365","article-title":"Cerebral infarction associated with oral verapamil overdose","volume":"26","author":"Samniah","year":"1988","journal-title":"J. Toxicol.: Clin. Toxicol."},{"issue":"6","key":"10.1016\/j.ibneur.2025.01.002_bib57","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1097\/HJH.0b013e3282fbd240","article-title":"Effect of antihypertensive agents on cerebral blood flow and flow velocity in acute ischaemic stroke: systematic review of controlled studies","volume":"26","author":"Sare","year":"2008","journal-title":"J. Hypertens."},{"issue":"5","key":"10.1016\/j.ibneur.2025.01.002_bib58","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1001\/jamainternmed.2019.7087","article-title":"Evaluation of a common prescribing cascade of calcium channel blockers and diuretics in older adults with hypertension","volume":"180","author":"Savage","year":"2020","journal-title":"JAMA Intern. Med."},{"issue":"1","key":"10.1016\/j.ibneur.2025.01.002_bib59","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s12028-007-0035-7","article-title":"Preliminary experience with intra-arterial nicardipine in patients with acute ischemic stroke","volume":"7","author":"Shah","year":"2007","journal-title":"Neurocrit. Care"},{"issue":"6","key":"10.1016\/j.ibneur.2025.01.002_bib60","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00000441-199212000-00005","article-title":"Case report: sustained-release verapamil overdose causing stroke: an unusual complication","volume":"304","author":"Shah","year":"1992","journal-title":"Am. J. Med. Sci."},{"issue":"1","key":"10.1016\/j.ibneur.2025.01.002_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-015-0279-3","article-title":"Impact of preadmission treatment with calcium channel blockers or beta blockers on short-term mortality after stroke: a nationwide cohort study","volume":"15","author":"Sundb\u00f8ll","year":"2015","journal-title":"BMC Neurol."},{"issue":"8","key":"10.1016\/j.ibneur.2025.01.002_bib62","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1097\/00004872-200108000-00005","article-title":"Effect of calcium antagonist or beta blockade treatment on nitric oxide-dependent vasodilation and oxidative stress in essential hypertensive patients","volume":"19","author":"Taddei","year":"2001","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ibneur.2025.01.002_bib63","doi-asserted-by":"crossref","unstructured":"Takakura, S., et al., Nilvadipine, a new calcium channel blocker, reduces ischemic brain injury in rats. 1991. 56(4): p. 547-550.","DOI":"10.1016\/S0021-5198(19)39850-6"},{"issue":"7653","key":"10.1016\/j.ibneur.2025.01.002_bib64","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/bmj.39548.738368.BE","article-title":"Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials.","volume":"336","author":"Trialists\u2019Collaboration","year":"2008","journal-title":"Bmj"},{"issue":"3","key":"10.1016\/j.ibneur.2025.01.002_bib65","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/10641963.2016.1246561","article-title":"Effect of antihypertensive treatment on the long-term outcome of patients discharged after acute ischemic stroke","volume":"39","author":"Tziomalos","year":"2017","journal-title":"Clin. Exp. Hypertens."},{"issue":"3","key":"10.1016\/j.ibneur.2025.01.002_bib66","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1161\/01.HYP.0000200710.29498.80","article-title":"A longitudinal study of hypertension risk factors and their relation to cardiovascular disease: the strong heart study","volume":"47","author":"Wang","year":"2006","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.ibneur.2025.01.002_bib67","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002487","article-title":"Risks of adverse events following coprescription of statins and calcium channel blockers: a nationwide population-based study","volume":"95","author":"Wang","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.ibneur.2025.01.002_bib68","article-title":"Incident stroke events in clinical trials of antihypertensive drugs in cardiovascular disease patients: a network meta-analysis of randomized controlled trials","author":"Wang","year":"2022","journal-title":"Curr. Probl. Cardiol."},{"issue":"23","key":"10.1016\/j.ibneur.2025.01.002_bib69","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1001\/jama.292.23.2849","article-title":"Association between cardiovascular outcomes and antihypertensive drug treatment in older women","volume":"292","author":"Wassertheil-Smoller","year":"2004","journal-title":"Jama"},{"key":"10.1016\/j.ibneur.2025.01.002_bib70","doi-asserted-by":"crossref","unstructured":"Yamamoto, L.Y., et al., efficacy of bypass between extracerebral artery and cerebral vein with retrograde verapamil infusion into focal cerebral ischemic tissue in rats. 1991. 29(5): p. 719-726.","DOI":"10.1227\/00006123-199111000-00013"},{"key":"10.1016\/j.ibneur.2025.01.002_bib71","doi-asserted-by":"crossref","unstructured":"Yamato, M., et al., Nifedipine treatment reduces brain damage after transient focal ischemia, possibly through its antioxidative effects. 2011. 34(7): p. 840-845.","DOI":"10.1038\/hr.2011.51"},{"key":"10.1016\/j.ibneur.2025.01.002_bib72","doi-asserted-by":"crossref","unstructured":"Yui, Y., et al., Comparison of nifedipine retard with angiotensin converting enzyme inhibitors in Japanese hypertensive patients with coronary artery disease: the Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) randomized trial. 2004. 27(3): p. 181-191.","DOI":"10.1291\/hypres.27.181"},{"key":"10.1016\/j.ibneur.2025.01.002_bib73","doi-asserted-by":"crossref","unstructured":"Zanchetti, A., et al., Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial. 2002. 106(19): p. 2422-2427.","DOI":"10.1161\/01.CIR.0000039288.86470.DD"}],"container-title":["IBRO Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266724212500003X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266724212500003X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T07:34:07Z","timestamp":1784360047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266724212500003X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":73,"alternative-id":["S266724212500003X"],"URL":"https:\/\/doi.org\/10.1016\/j.ibneur.2025.01.002","relation":{},"ISSN":["2667-2421"],"issn-type":[{"value":"2667-2421","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Examining the therapeutic potential and side effects of calcium channel blockers in mortality and morbidity of patients with stroke: A systematic review of pre-clinical and clinical studies","name":"articletitle","label":"Article Title"},{"value":"IBRO Neuroscience Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ibneur.2025.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of International Brain Research Organization.","name":"copyright","label":"Copyright"}]}}